Predictions
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.51
14.04.24
14.04.24
-
14.04.25
14.04.25
-0.66%
28.04.24
28.04.24
Globe Life Inc.
Start price
Target price
Perf. (%)
€55.50
14.04.24
14.04.24
-
14.04.25
14.04.25
27.03%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Micron Technology Inc.
Start price
Target price
Perf. (%)
€114.20
14.04.24
14.04.24
-
14.04.25
14.04.25
-10.49%
22.04.24
22.04.24
Informatica Inc.
Start price
Target price
Perf. (%)
€38.80
14.04.24
14.04.24
-
14.04.25
14.04.25
-22.14%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Heidelberger Druckmaschinen AG
Start price
Target price
Perf. (%)
€1.01
13.04.24
13.04.24
-
13.04.25
13.04.25
-10.57%
27.04.24
27.04.24
Q32 Bio Inc.
Start price
Target price
Perf. (%)
€14.94
13.04.24
13.04.24
-
13.04.25
13.04.25
-
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Entera Bio
Start price
Target price
Perf. (%)
€2.32
13.04.24
13.04.24
-
13.04.25
13.04.25
-19.83%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Liquidia Technologies Inc
Start price
Target price
Perf. (%)
€13.78
13.04.24
13.04.24
€12.00
13.04.25
13.04.25
-18.00%
27.04.24
27.04.24
Probably not worthwhile Investment
EBIT decline/stagnation expected
Low dividend yield expected
Revenue decline/stagnation expected
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.07
13.04.24
13.04.24
€1.00
13.04.25
13.04.25
-2.80%
27.04.24
27.04.24
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Inotiv Inc.
Start price
Target price
Perf. (%)
€5.50
13.04.24
13.04.24
€4.00
13.04.25
13.04.25
-32.36%
27.04.24
27.04.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€22.07
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
-5.44%
27.04.24
27.04.24
Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.51
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
-0.66%
27.04.24
27.04.24
negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
Anebulo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.72
13.04.24
13.04.24
€3.00
13.04.25
13.04.25
-7.35%
27.04.24
27.04.24
Alterity Therapeutics Ltd. ADR
Start price
Target price
Perf. (%)
€3.80
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
-56.84%
27.04.24
27.04.24
Protagenic Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.26
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
2.38%
27.04.24
27.04.24
Adicet Bio Inc.
Start price
Target price
Perf. (%)
€1.97
13.04.24
13.04.24
€20.00
13.04.25
13.04.25
-14.68%
27.04.24
27.04.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected